Trials / Completed
CompletedNCT05832983
Aromatherapy and Anxiety Study
The Effect of Aromatherapy on Situational Anxiety in Adults Receiving Intra-Articular Injections in the Ambulatory Clinic Setting
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
While intra-articular injections can alleviate pain in orthopedic patients, this can be an anxiety-provoking experience. Adult patients scheduled to receive an injection at the study location will be randomly assigned to one of three groups. The control group (C) will receive the current standard of nursing care. The first experimental group (A) will receive a guided meditation prior to receiving the injection. The second experimental group (B) will receive an Elequil Aromatab and the same guided meditation prior to receiving the injection.
Detailed description
The objective of the study is to measure the difference in anxiety levels of adult orthopedic patients in need of intra-articular injections who receive a guided meditation only prior to their injection, compared to those who receive a guided meditation and an aromatherapy Elequil Aromatab prior to injection, as well as compared with those who receive the usual standard of care
Conditions
- Anxiety Related to Pain Related to an Intraarticular Injection
- Pain Related to an Intraarticular Injection
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Guided Meditation | In private exam room, the study registered nurse (RN) will read a prepared two minute guided meditation to patient. |
| OTHER | Aromatherapy | In private exam room, study RN will first affix an Elequil Aromatab to patient's clothing on either their upper arm or chest (whichever the patient prefers and/or as clothing allows). |
Timeline
- Start date
- 2023-07-04
- Primary completion
- 2024-02-21
- Completion
- 2024-02-21
- First posted
- 2023-04-27
- Last updated
- 2025-03-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05832983. Inclusion in this directory is not an endorsement.